Our SNV/INDEL results revealed POLE mutations (c.1376C>T p.S459F) occurring at frequencies of 18.53% and 42.8% in LELC and carcinosarcoma (Figure 4), respectively. This evidence concerns the gene POLE and carcinosarcoma.